Stammdaten
Guardant Health, Inc., ein Präzisions-Onkologie-Unternehmen, bietet Bluttests, Datensätze und Analysen in den Vereinigten Staaten und international an. Das Unternehmen bietet Guardant360, Guardant360 LDT, Guardant360 CDx und GuardantOMNI Flüssigbiopsie-basierte Tests für fortgeschrittene Krebsstadien an; sowie GuardantINFORM, eine In-silico-Forschungsplattform, die einen klinisch-genomischen Flüssigbiopsie-Datensatz von fortgeschrittenen Krebspatienten umfasst. Es entwickelt auch den LUNAR-2-Test zur Früherkennung von Darmkrebs bei berechtigten asymptomatischen Personen; und GuardantConnect, eine integrierte softwaregestützte Lösung für klinische und biopharmaze utische Kunden, die Patienten, die mit dem Guardant360-Assay getestet wurden, mit verwertbaren Alterationen mit möglicherweise relevanten klinischen Studien verbinden möchten. Darüber hinaus bietet das Unternehmen Guardant Reveal Test zur Auswahl neoadjuvanter und adjuvanter Behandlung bei Frühstadium-Krebspatienten an; Guardant360 Gewebegenotypisierungsprodukt; und Guardant-19 zur Verwendung bei der Erkennung des neuartigen Coronavirus. Ferner bietet es Entwicklungsservices an, darunter die Entwicklung begleitender Diagnostika und behördliche Genehmigung, Einrichtung klinischer Studien, Überwachung und Wartung, Testentwicklung und Unterstützung sowie mit Kits verbundene Erfüllungsservices für biopharmaze utische Unternehmen und medizinische Einrichtungen. Das Unternehmen wurde 2011 gegründet und hat seinen Sitz in Redwood City, Kalifornien. KI
Unternehmen & Branche
| Name | Guardant Health, Inc. |
|---|---|
| Ticker | GH |
| CIK | 0001576280 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Diagnostik & Labore |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | 40131M109 |
|---|---|
| ISIN | US40131M1099 |
| Typ | Common Stock |
| Marktkapitalisierung | 19,25 Mrd. USD |
| Beta | 1,62 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 3100 HANOVER STREET, 94304 PALO ALTO, CA |
| Telefon | 855-698-8887 |
| EIN (IRS) | 45-4139254 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
Bewertung
| KUV (P/S) | 19,60 vs. 27,24 (2021) ▼ |
|---|---|
| FCF-Rendite | -1,2 % vs. -2,8 % (2021) ▲ |
| Buyback-Rendite | 0,2 % |
Qualität & Bilanz
| Bruttomarge | 64,5 % |
|---|---|
| Operative Marge | -44,5 % vs. -110,0 % (2021) ▲ |
| Nettomarge | -42,4 % vs. -103,0 % (2021) ▲ |
| ROIC | -25,8 % vs. -43,5 % (2021) ▲ |
| Zinsdeckungsgrad | -112,2 vs. -159,5 (2021) ▲ |
| Forderungslaufzeit (DSO) | 51 T vs. 95 T (2021) ▼ |
| Lagerreichweite (DIO) | 90 T |
| Verbindlichkeitslaufzeit (DPO) | 57 T |
| Cash-Conversion-Cycle (CCC) | 84 T |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 15,78 | 46,38 | 20,73 | – | – | – | |
| KUV (P/S) | 27,24 | 6,21 | 5,83 | 5,13 | 13,59 | 17,82 | |
| FCF-Rendite | -2,8 % | -13,9 % | -10,5 % | -7,3 % | -1,7 % | -1,2 % | |
| Buyback-Rendite | – | – | 0,0 % | 0,0 % | 0,3 % | 0,0 % | |
| Qualität & Bilanz | |||||||
| Bruttomarge | – | – | 59,7 % | 60,8 % | 64,5 % | 64,9 % | |
| Operative Marge | -110,0 % | -121,1 % | -100,1 % | -60,0 % | -44,5 % | -41,4 % | |
| Nettomarge | -103,0 % | -145,6 % | -85,0 % | -59,0 % | -42,4 % | -40,1 % | |
| ROIC | -43,5 % | -224,1 % | -128,7 % | -36,5 % | -25,8 % | -28,4 % | |
| Zinsdeckungsgrad | -159,5 | -211,2 | -219,1 | -171,9 | -112,2 | -100,5 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
GH
Guardant Health, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 61 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv
Risiko-Ausstieg
Handelsvolumen
Hoch
Insider
0,0
Keine Insider-Käufe
Institutionell
37,6
81 neu, 209 erhöht, -1266074K $ netto
Aktivist
29,6
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 138.71 | +3.5 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 105.97 | +35.5 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 150.19 | EMA50: 138.74 | |
| MACD-Histogramm | Bärisch | 10 % | -3.098 | Bearisch | |
| RSI(14) | Neutral | 10 % | 45.3 | Neutral (30–70) | |
| Stoch %K(14) | Bullisch | 5 % | 7.8 | Überverkauft | |
| ADX(14)+DI | Bärisch | 10 % | 29.9 | +DI: 20.1 / −DI: 22.2 | |
| Z-Score(60) | Neutral | 5 % | 0.52 | In Range | |
| 52W-Position | Neutral | 5 % | 79.1 % | Hoch 170.77 / Tief 40.98 | |
| Bollinger(20,2σ) | Bullisch | 5 % | 8.9 % | Upper 172.26 / Mid 156.54 / Lower 140.83 | |
| LinReg-Slope(60) | Bullisch | 10 % | +1.2310 | R²=0.82 / annualisiert +236.3 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-16 | Tariq Musa | Director | Open Market Sale | -116 | 163,29 | -18.941,64 | -1,5% | |
| 2026-06-29 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -70.513 | 151,47 | -10.680.315,01 | -861,7% | |
| 2026-06-29 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -46.663 | 152,20 | -7.102.318,58 | -573,0% | |
| 2026-06-29 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -25.812 | 150,53 | -3.885.433,90 | -313,5% | |
| 2026-06-29 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -40 | 153,00 | -6.120,00 | -0,5% | |
| 2026-06-26 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -64.037 | 150,49 | -9.636.838,48 | -777,5% | |
| 2026-06-26 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -52.935 | 151,16 | -8.001.628,13 | -645,6% | |
| 2026-06-22 | POTTER MYRTLE S | Director | Open Market Sale | -1.556 | 131,16 | -204.084,96 | -16,5% | |
| 2026-06-22 | Tariq Musa | Director | Open Market Sale | -1.951 | 131,16 | -255.893,16 | -20,6% | |
| 2026-06-16 | Tariq Musa | Director | Open Market Sale | -116 | 130,19 | -15.102,04 | -1,2% | |
| 2026-06-15 | Kalia Kumud | Officer, Chief Information Officer | Open Market Purchase | 600 | 130,76 | 78.456,00 | +6,3% | |
| 2026-06-15 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -600 | 131,08 | -78.648,00 | -6,3% | |
| 2026-06-11 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -3.418 | 130,24 | -445.155,53 | -35,9% | |
| 2026-06-10 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -5.000 | 130,41 | -652.030,00 | -52,6% | |
| 2026-06-10 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -600 | 130,86 | -78.516,00 | -6,3% | |
| 2026-06-05 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -49.716 | 125,57 | -6.242.788,40 | -503,7% | |
| 2026-06-05 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -33.843 | 126,33 | -4.275.260,97 | -344,9% | |
| 2026-06-05 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -13.787 | 128,25 | -1.768.197,92 | -142,7% | |
| 2026-06-05 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -1.100 | 127,02 | -139.726,51 | -11,3% | |
| 2026-06-05 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -900 | 131,78 | -118.605,96 | -9,6% | |
| 2026-06-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -2.000 | 128,62 | -257.240,60 | -20,8% | |
| 2026-06-05 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -554 | 130,21 | -72.133,79 | -5,8% | |
| 2026-06-05 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -100 | 132,55 | -13.255,00 | -1,1% | |
| 2026-06-04 | Krognes Steve E. | Director | Open Market Sale | -9.294 | 132,51 | -1.231.521,92 | -99,4% | |
| 2026-06-03 | Joyce Meghan V. | Director | Open Market Sale | -106 | 129,31 | -13.706,98 | -1,1% | |
| 2026-06-03 | Joyce Meghan V. | Director | Open Market Sale | -5.728 | 127,11 | -728.059,73 | -58,7% | |
| 2026-06-03 | Joyce Meghan V. | Director | Open Market Sale | -3.516 | 126,52 | -444.829,20 | -35,9% | |
| 2026-06-03 | Joyce Meghan V. | Director | Open Market Sale | -650 | 128,02 | -83.212,74 | -6,7% | |
| 2026-05-28 | Hidalgo Medina Manuel | Director | Open Market Sale | -1.000 | 130,06 | -130.060,10 | -10,5% | |
| 2026-05-27 | Saia John G. | Officer, Chief Legal Officer | Open Market Sale | -6 | 126,08 | -756,48 | -0,1% | |
| 2026-05-27 | Saia John G. | Officer, Chief Legal Officer | Open Market Sale | -9.994 | 125,08 | -1.250.079,50 | -100,9% | |
| 2026-05-22 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -24.406 | 118,67 | -2.896.360,08 | -233,7% | |
| 2026-05-20 | Hidalgo Medina Manuel | Director | Open Market Sale | -1.000 | 107,10 | -107.095,60 | -8,6% | |
| 2026-05-20 | Hidalgo Medina Manuel | Director | Open Market Sale | -250 | 107,07 | -26.768,25 | -2,2% | |
| 2026-05-20 | CLARK IAN T | Director | Open Market Sale | -6.876 | 106,90 | -735.048,53 | -59,3% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -37.900 | 112,02 | -4.245.546,63 | -342,6% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -37.163 | 111,14 | -4.130.470,49 | -333,3% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -33.069 | 108,11 | -3.574.960,62 | -288,4% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -28.908 | 110,10 | -3.182.652,28 | -256,8% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -26.352 | 112,76 | -2.971.430,44 | -239,7% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -21.171 | 106,99 | -2.265.125,51 | -182,8% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -11.919 | 105,01 | -1.251.589,16 | -101,0% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -9.852 | 108,97 | -1.073.546,82 | -86,6% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -1.366 | 103,82 | -141.815,11 | -11,4% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -1.200 | 105,88 | -127.050,00 | -10,3% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -900 | 102,57 | -92.313,00 | -7,4% | |
| 2026-05-20 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -200 | 100,95 | -20.190,00 | -1,6% | |
| 2026-05-20 | Saia John G. | Officer, Chief Legal Officer | Open Market Sale | -7.187 | 106,71 | -766.939,14 | -61,9% | |
| 2026-05-20 | Saia John G. | Officer, Chief Legal Officer | Open Market Sale | -5.632 | 105,34 | -593.293,47 | -47,9% | |
| 2026-05-20 | Saia John G. | Officer, Chief Legal Officer | Open Market Sale | -7.181 | 107,23 | -769.996,37 | -62,1% | |
| 2026-05-18 | Tariq Musa | Director | Open Market Sale | -116 | 95,96 | -11.131,36 | -0,9% | |
| 2026-05-12 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -50.000 | 100,32 | -5.016.000,00 | -404,7% | |
| 2026-04-16 | Tariq Musa | Director | Open Market Sale | -116 | 84,83 | -9.840,28 | -0,8% | |
| 2026-04-06 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3.832 | 92,68 | -355.149,76 | -28,7% | |
| 2026-03-18 | Tariq Musa | Director | Open Market Sale | -348 | 88,09 | -30.655,32 | -2,5% | |
| 2026-03-16 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -3.000 | 87,04 | -261.111,00 | -21,1% | |
| 2026-03-06 | Hidalgo Medina Manuel | Director | Open Market Sale | -1.000 | 91,61 | -91.606,50 | -7,4% | |
| 2026-03-06 | Hidalgo Medina Manuel | Director | Open Market Sale | -300 | 91,30 | -27.390,03 | -2,2% | |
| 2026-03-04 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -26.980 | 95,12 | -2.566.310,62 | -207,1% | |
| 2026-03-04 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -13.020 | 95,73 | -1.246.349,92 | -100,6% | |
| 2026-01-21 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -1.703 | 112,34 | -191.318,09 | -15,4% | |
| 2026-01-21 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3.249 | 115,70 | -375.902,15 | -30,3% | |
| 2026-01-21 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3.619 | 113,48 | -410.681,59 | -33,1% | |
| 2026-01-07 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -6.311 | 111,75 | -705.267,50 | -56,9% | |
| 2026-01-07 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3.632 | 112,62 | -409.029,30 | -33,0% | |
| 2026-01-07 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -88 | 113,44 | -9.982,69 | -0,8% | |
| 2025-12-17 | Tariq Musa | Director | Open Market Sale | -116 | 101,46 | -11.769,36 | -0,9% | |
| 2025-12-15 | Chudova Darya | Officer, Chief Technology Officer | Open Market Sale | -5.451 | 104,04 | -567.131,85 | -45,8% | |
| 2025-12-15 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -83.945 | 103,80 | -8.713.591,73 | -703,1% | |
| 2025-12-15 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -6.620 | 104,02 | -688.628,29 | -55,6% | |
| 2025-12-08 | Chudova Darya | Officer, Chief Technology Officer | Open Market Sale | -13.664 | 105,04 | -1.435.226,93 | -115,8% | |
| 2025-12-08 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -2.000 | 104,60 | -209.204,20 | -16,9% | |
| 2025-12-08 | Chudova Darya | Officer, Chief Technology Officer | Open Market Sale | -9.271 | 106,00 | -982.752,89 | -79,3% | |
| 2025-12-08 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -30.760 | 105,34 | -3.240.172,27 | -261,4% | |
| 2025-12-08 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -15.000 | 104,21 | -1.563.124,50 | -126,1% | |
| 2025-12-08 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -4.240 | 106,00 | -449.440,00 | -36,3% | |
| 2025-12-08 | Hidalgo Medina Manuel | Director | Open Market Sale | -1.000 | 105,00 | -105.000,00 | -8,5% | |
| 2025-12-08 | Hidalgo Medina Manuel | Director | Open Market Sale | -250 | 105,00 | -26.250,00 | -2,1% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -8.033 | 101,42 | -814.735,78 | -65,7% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -7.567 | 103,26 | -781.394,15 | -63,0% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -5.568 | 106,68 | -594.018,18 | -47,9% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -5.027 | 103,96 | -522.611,44 | -42,2% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -3.284 | 106,70 | -350.408,38 | -28,3% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -3.267 | 101,46 | -331.482,89 | -26,7% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -2.533 | 103,24 | -261.509,20 | -21,1% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -1.190 | 107,26 | -127.642,38 | -10,3% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -250 | 105,82 | -26.454,00 | -2,1% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -11.969 | 102,09 | -1.221.970,27 | -98,6% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -6.555 | 103,97 | -681.534,49 | -55,0% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -4.084 | 101,40 | -414.128,63 | -33,4% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -3.414 | 103,25 | -352.505,06 | -28,4% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -2.964 | 106,71 | -316.282,81 | -25,5% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -744 | 102,31 | -76.115,66 | -6,1% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -478 | 101,43 | -48.482,44 | -3,9% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -400 | 105,99 | -42.394,52 | -3,4% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -372 | 103,48 | -38.495,12 | -3,1% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -244 | 104,10 | -25.400,03 | -2,0% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -228 | 106,63 | -24.312,14 | -2,0% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -22.891 | 102,11 | -2.337.301,58 | -188,6% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -11.978 | 103,96 | -1.245.252,04 | -100,5% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -8.774 | 102,11 | -895.931,57 | -72,3% | |
| 2025-12-05 | CLARK IAN T | Director | Open Market Sale | -17.055 | 107,27 | -1.829.494,97 | -147,6% | |
| 2025-12-05 | CLARK IAN T | Director | Open Market Sale | -8.156 | 106,67 | -869.967,90 | -70,2% | |
| 2025-12-05 | CLARK IAN T | Director | Open Market Sale | -3.400 | 108,05 | -367.354,36 | -29,6% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -664 | 107,85 | -71.612,40 | -5,8% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -23.974 | 106,15 | -2.544.840,10 | -205,3% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -18.576 | 105,33 | -1.956.610,08 | -157,9% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -6.786 | 106,90 | -725.423,40 | -58,5% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -2.444 | 106,18 | -259.503,92 | -20,9% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -1.923 | 105,33 | -202.549,59 | -16,3% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -800 | 107,03 | -85.624,00 | -6,9% | |
| 2025-11-19 | Tariq Musa | Director | Open Market Sale | -116 | 96,25 | -11.165,00 | -0,9% | |
| 2025-11-07 | Hidalgo Medina Manuel | Director | Open Market Sale | -500 | 95,23 | -47.615,05 | -3,8% | |
| 2025-11-07 | Hidalgo Medina Manuel | Director | Open Market Sale | -1.000 | 95,17 | -95.165,10 | -7,7% | |
| 2025-11-07 | Saia John G. | Officer, Chief Legal Officer | Open Market Sale | -8.996 | 96,25 | -865.865,00 | -69,9% | |
| 2025-10-17 | Tariq Musa | Director | Open Market Sale | -116 | 66,95 | -7.766,20 | -0,6% | |
| 2025-10-17 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 66,95 | -1.740,70 | -0,1% | |
| 2025-09-17 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 55,63 | -1.446,38 | -0,1% | |
| 2025-09-17 | Tariq Musa | Director | Open Market Sale | -116 | 55,63 | -6.453,08 | -0,5% | |
| 2025-09-12 | Hidalgo Medina Manuel | Director | Open Market Sale | -2.165 | 54,16 | -117.250,77 | -9,5% | |
| 2025-09-09 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -5.277 | 59,93 | -316.274,88 | -25,5% | |
| 2025-09-09 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -294.723 | 59,44 | -17.519.720,32 | -1413,6% | |
| 2025-09-02 | Joyce Meghan V. | Director | Open Market Sale | -100 | 65,84 | -6.584,00 | -0,5% | |
| 2025-08-21 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -2.000 | 61,76 | -123.510,00 | -10,0% | |
| 2025-08-19 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 59,02 | -1.534,52 | -0,1% | |
| 2025-08-19 | Tariq Musa | Director | Open Market Sale | -116 | 59,02 | -6.846,32 | -0,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 3189 von typischerweise 8405 Fonds (38 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 38.548.759 | 0 | 38.548.759 | 1.107.270.970 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.624.180 | 0 | 5.624.180 | 519.505.507 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 4.554.839 | 0 | 4.554.839 | 409.938.143 | Neu | +100,0% | |
| FMR LLC | 16.167.081 | 0 | 16.167.081 | 396.901.100 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 4.229.531 | 0 | 4.229.531 | 390.681.778 | Neu | +100,0% | |
| BAILLIE GIFFORD & CO | 3.859.046 | 0 | 3.859.046 | 356.460.078 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3.508.883 | 0 | 3.508.883 | 324.172.637 | Neu | +100,0% | |
| Capital International Investors | 3.481.318 | 0 | 3.481.318 | 321.569.344 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 3.448.193 | 0 | 3.448.193 | 318.509.548 | Neu | +100,0% | |
| Deep Track Capital, LP | 3.338.241 | 0 | 3.338.241 | 308.353.321 | Neu | +100,0% | |
| STATE STREET CORP | 27.127.620 | 0 | 27.127.620 | 299.799.710 | Neu | +100,0% | |
| LINDEN ADVISORS LP | 212.760.000 | 0 | 212.760.000 | 294.427.689 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 177.959.375 | 0 | 177.959.375 | 286.425.599 | Neu | +100,0% | |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.550.314 | 0 | 2.550.314 | 235.572.468 | Neu | +100,0% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.362.379 | 0 | 2.362.379 | 218.087.540 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 1.905.637 | 0 | 1.905.637 | 194.641.763 | Neu | +100,0% | |
| FEDERATED HERMES, INC. | 1.887.584 | 0 | 1.887.584 | 174.356.133 | Neu | +100,0% | |
| MORGAN STANLEY | 13.207.324 | 0 | 13.207.324 | 157.048.545 | Neu | +100,0% | |
| ARISTEIA CAPITAL, L.L.C. | 144.220.000 | 0 | 144.220.000 | 155.442.454 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.623.511 | 0 | 1.623.511 | 149.963.711 | Neu | +100,0% | |
| BRAIDWELL LP | 61.453.712 | 0 | 61.453.712 | 148.733.898 | Neu | +100,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.524.282 | 0 | 1.524.282 | 140.797.928 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 1.489.566 | 0 | 1.489.566 | 137.591.211 | Neu | +100,0% | |
| RTW INVESTMENTS, LP | 1.481.033 | 0 | 1.481.033 | 136.803.018 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 1.461.386 | 0 | 1.461.386 | 134.988.084 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.451.803 | 0 | 1.451.803 | 134.103.043 | Neu | +100,0% | |
| UBS Group AG | 1.537.137 | 0 | 1.537.137 | 130.920.901 | Neu | +100,0% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.362.539 | 0 | 1.362.539 | 125.857.727 | Neu | +100,0% | |
| Hood River Capital Management LLC | 1.310.065 | 0 | 1.310.065 | 121.010.704 | Neu | +100,0% | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1.212.915 | 0 | 1.212.915 | 112.036.959 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 15.638.241 | 0 | 15.638.241 | 111.411.827 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1.205.701 | 0 | 1.205.701 | 111.370.601 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 10.909.563 | 0 | 10.909.563 | 106.578.546 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1.112.439 | 0 | 1.112.439 | 102.755.991 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 7.016.595 | 0 | 7.016.595 | 100.041.630 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 10.579.221 | 0 | 10.579.221 | 92.644.152 | Neu | +100,0% | |
| Temasek Holdings (Private) Ltd | 985.571 | 0 | 985.571 | 91.037.193 | Neu | +100,0% | |
| Erste Asset Management GmbH | 577.313 | 815.917 | -238.604 | 88.756.101 | Reduziert | -29,2% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 951.114 | 0 | 951.114 | 87.854.400 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 11.250.840 | 0 | 11.250.840 | 87.021.159 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 867.537 | 0 | 867.537 | 80.134.496 | Neu | +100,0% | |
| EMERALD ADVISERS, LLC | 841.917 | 0 | 841.917 | 77.767.873 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 816.095 | 0 | 816.095 | 75.382.695 | Neu | +100,0% | |
| Artisan Partners Limited Partnership | 814.571 | 0 | 814.571 | 75.241.878 | Neu | +100,0% | |
| VOYA INVESTMENT MANAGEMENT LLC | 17.775.034 | 0 | 17.775.034 | 73.827.264 | Neu | +100,0% | |
| CADIAN CAPITAL MANAGEMENT, LP | 779.648 | 0 | 779.648 | 72.016.086 | Neu | +100,0% | |
| Aequim Alternative Investments LP | 42.500.000 | 0 | 42.500.000 | 71.520.471 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 12.260.650 | 0 | 12.260.650 | 64.907.905 | Neu | +100,0% | |
| CITIGROUP INC | 33.041.072 | 0 | 33.041.072 | 63.001.483 | Neu | +100,0% | |
| FRED ALGER MANAGEMENT, LLC | 622.259 | 0 | 622.259 | 57.478.064 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 3189 von typischerweise 8405 Fonds (38 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Erste Asset Management GmbH | 577.313 | 815.917 | -29,2% | 88.756.101 | 27,44 | 100 % | 17 Q |
| NEW YORK STATE COMMON RETIREMENT FUND | 272.671 | 149.615 | +82,2% | 40.908.830 | 12,65 | 100 % | 17 Q |
| Stephens Investment Management Group LLC | 254.310 | 0 | +100,0% | 38.154.129 | 11,79 | 0 % | 1 Q |
| Rathbones Group PLC | 175.584 | 166.507 | +5,5% | 26.342.867 | 8,14 | 100 % | 17 Q |
| Portman Square Capital LLP | 94.800 | 10.100.000 | -99,1% | 14.222.844 | 4,40 | 100 % | 7 Q |
| MACKAY SHIELDS LLC | 7.179.000 | 0 | +100,0% | 8.928.130 | 2,76 | 1 % | 6 Q |
| Police & Firemen's Retirement System of New Jersey | 57.546 | 33.510 | +71,7% | 8.633.626 | 2,67 | 100 % | 7 Q |
| Slow Capital, Inc. | 52.547 | 53.724 | -2,2% | 7.883.627 | 2,44 | 100 % | 2 Q |
| Y-Intercept (Hong Kong) Ltd | 52.547 | 0 | +100,0% | 7.883.626 | 2,44 | 100 % | 10 Q |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | 52.362 | 0 | +100,0% | 7.855.863 | 2,43 | 0 % | 1 Q |
| RATIONAL ADVISORS, INC. | 5.429.000 | 2.049.000 | +165,0% | 6.751.504 | 2,09 | 0 % | 2 Q |
| Capricorn Fund Managers Ltd | 31.775 | 0 | +100,0% | 4.767.203 | 1,47 | 100 % | 3 Q |
| Krilogy Financial LLC | 28.924 | 32.436 | -10,8% | 4.339.468 | 1,34 | 0 % | 2 Q |
| Simplify Asset Management Inc. | 27.571 | 20.821 | +32,4% | 4.136.477 | 1,28 | 100 % | 5 Q |
| China Universal Asset Management Co., Ltd. | 21.103 | 23.277 | -9,3% | 3.166.083 | 0,98 | 100 % | 17 Q |
| ZAZOVE ASSOCIATES LLC | 2.500.000 | 0 | +100,0% | 3.106.249 | 0,96 | – | 10 Q |
| Fideuram Asset Management (Ireland) dac | 20.551 | 205 | +9924,9% | 2.586.839 | 0,80 | 0 % | 2 Q |
| Values First Advisors, Inc. | 2 | 20.765 | -100,0% | 2.469.305 | 0,76 | 0 % | 17 Q |
| TrueMark Investments, LLC | 13.160 | 6.596 | +99,5% | 1.974.395 | 0,61 | 0 % | 2 Q |
| D.A. DAVIDSON & CO. | 12.526 | 30.718 | -59,2% | 1.879.276 | 0,58 | 100 % | 16 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 138 | 18,6 | 309 |
| 31.03.2026 | ✓ | 502 | 1.174,2 | 13.583 |
| 31.12.2025 | ✓ | 507 | 1.210,4 | 14.646 |
| 30.09.2025 | ✓ | 415 | 1.198,0 | 8.533 |
| 30.06.2025 | ✓ | 383 | 1.221,4 | 7.334 |
| 31.03.2025 | ✓ | 365 | 1.330,9 | 6.421 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 951.114 | 87.854.400 |
| ORBIMED ADVISORS LLC | 435.200 | 40.199.424 |
| Boussard & Gavaudan Investment Management LLP | 23.200 | 38.262.515 |
| BROWN ADVISORY INC | 329.564 | 30.441.827 |
| SAMLYN CAPITAL, LLC | 249.137 | 23.012.786 |
| Portman Square Capital LLP | 10.000.000 | 16.828.346 |
| ADVENT CAPITAL MANAGEMENT /DE/ | 12.009.000 | 12.402.150 |
| Kinetic Partners Management, LP | 129.900 | 11.998.863 |
| Caption Management, LLC | 115.183 | 10.639.454 |
| BLAIR WILLIAM & CO/IL | 103.644 | 9.573.596 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 177.943.475 | 83.266.418 | +87.9 % | 284.956.916 |
| LINDEN ADVISORS LP | 212.760.000 | 34.000.000 | +19.0 % | 294.427.689 |
| CITIGROUP INC | 33.041.072 | 28.030.184 | +559.4 % | 63.001.483 |
| ARISTEIA CAPITAL, L.L.C. | 144.220.000 | 23.500.000 | +19.5 % | 155.442.454 |
| MORGAN STANLEY | 13.207.324 | 11.933.025 | +936.4 % | 157.048.545 |
| WELLINGTON MANAGEMENT GROUP LLP | 10.909.563 | 10.503.044 | +2583.7 % | 106.578.546 |
| Jefferies Financial Group Inc. | 10.394.879 | 9.426.961 | +973.9 % | 18.184.814 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 8.745.000 | 6.042.761 | +223.6 % | 9.031.295 |
| BANK OF AMERICA CORP /DE/ | 10.579.221 | 5.194.575 | +96.5 % | 92.644.152 |
| Aequim Alternative Investments LP | 42.500.000 | 2.495.000 | +6.2 % | 71.520.471 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| VOYA INVESTMENT MANAGEMENT LLC | 17.775.034 | -117.305.395 | -86.8 % | 73.827.264 |
| BRAIDWELL LP | 61.453.712 | -43.400.288 | -41.4 % | 148.733.898 |
| WOLVERINE ASSET MANAGEMENT LLC | 27.256.000 | -30.500.000 | -52.8 % | 45.888.849 |
| Point72 Asset Management, L.P. | 11.195.940 | -29.670.229 | -72.6 % | 81.950.046 |
| BlackRock, Inc. | 38.548.759 | -18.488.955 | -32.4 % | 1.107.270.970 |
| LAZARD ASSET MANAGEMENT LLC | 49.929.419 | -11.218.166 | -18.3 % | 2.771.439 |
| CITADEL ADVISORS LLC | 15.475.941 | -6.715.401 | -30.3 % | 96.420.176 |
| LORD, ABBETT & CO. LLC | 9.043.113 | -4.056.870 | -31.0 % | 187.407 |
| CSS LLC/IL | 7.014.000 | -3.986.000 | -36.2 % | 11.804.885 |
| AGF MANAGEMENT LTD | 189.952 | -3.091.304 | -94.2 % | 17.545.866 |
Zusätzlich aktuell von 281 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 28.07.2026 | BlackRock, Inc. | Passiv (13G/A) | 5,20 % | 6.895.256 | -2,30 pp | |
| 15.05.2026 | T. Rowe Price Associates, Inc. | Passiv (13G) | 5,40 % | 7.035.771 | Neu | |
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,02 % | 6.589.394 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -9,18 pp | |
| 15.05.2025 | Deep Track Biotechnology Master Fund, Ltd. (+2) | Passiv (13G/A) | 4,41 % | 5.443.721 | -0,94 pp | |
| 17.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 7,50 % | 9.288.801 | Neu | |
| 13.02.2025 | Cadian Capital Management GP, LLC (+2) | Passiv (13G/A) | 4,20 % | 5.221.565 | -1,50 pp | |
| 10.02.2025 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 3,90 % | 4.850.271 | -4,33 pp | |
| 13.11.2024 | Cadian Capital Management GP, LLC (+2) | Passiv (13G) | 5,70 % | 7.007.974 | Neu | |
| 08.11.2024 | Wellington Management Company LLP | Passiv (13G) | 8,17 % | 10.051.230 | Neu | |
| 08.11.2024 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G) | 8,23 % | 10.127.528 | Neu | |
| 07.10.2024 | Deep Track Biotechnology Master Fund, Ltd. (+2) | Passiv (13G) | 5,35 % | 6.580.257 | +0,47 pp | |
| 07.10.2024 | Deep Track Biotechnology Master Fund, Ltd. (+2) | Passiv (13G/A) | 4,88 % | 6.000.560 | -0,87 pp | |
| 05.07.2024 | Baillie Gifford & Co (Scottish partnership) | Passiv (13G/A) | 4,98 % | 6.093.286 | -0,26 pp | |
| 12.04.2024 | Deep Track Biotechnology Master Fund, Ltd. (+2) | Passiv (13G) | 5,75 % | 7.000.000 | Neu | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,18 % | 11.130.601 | +0,35 pp | |
| 09.02.2024 | Capital International Investors | Passiv (13G/A) | 3,40 % | 4.013.661 | -4,30 pp | |
| 29.01.2024 | Baillie Gifford & Co (Scottish partnership) | Passiv (13G) | 5,24 % | 6.178.812 | Neu | |
| 25.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 8,90 % | 10.831.716 | +3,50 pp | |
| 14.02.2023 | Viking Global Performance LLC | Passiv (13G/A) | 2,90 % | 2.963.668 | -0,50 pp | |
| 14.02.2023 | Viking Global Equities II LP | Passiv (13G/A) | 0,06 % | 59.277 | -0,04 pp | |
| 14.02.2023 | Viking Global Equities Master Ltd. | Passiv (13G/A) | 2,80 % | 2.904.391 | -0,50 pp | |
| 14.02.2023 | Viking Global Investors LP (+3) | Passiv (13G/A) | 4,00 % | 4.107.644 | -1,00 pp | |
| 14.02.2023 | Viking Long Fund Master Ltd. (+1) | Passiv (13G/A) | 1,10 % | 1.143.976 | -0,20 pp | |
| 13.02.2023 | Capital International Investors | Passiv (13G) | 7,70 % | 7.879.355 | Neu | |
| 13.02.2023 | Capital Research Global Investors | Passiv (13G/A) | 2,00 % | 2.001.782 | -5,80 pp | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 8,83 % | 9.040.240 | +0,21 pp | |
| 03.02.2023 | . BlackRock, Inc. | Passiv (13G) | 5,40 % | 5.495.293 | +0,50 pp | |
| 09.12.2022 | Morgan Stanley | Passiv (13G/A) | 4,80 % | 4.953.699 | -0,80 pp | |
| 09.12.2022 | Morgan Stanley Investment Management Inc. | Passiv (13G/A) | 4,50 % | 4.634.655 | -0,90 pp | |
| 09.03.2022 | . BlackRock, Inc. | Passiv (13G/A) | 4,90 % | 4.961.865 | -0,10 pp | |
| 11.02.2022 | Capital Research Global Investors | Passiv (13G) | 7,80 % | 7.927.702 | Neu | |
| 10.02.2022 | The Vanguard Group | Passiv (13G/A) | 8,62 % | 8.762.086 | +1,00 pp | |
| 10.02.2022 | Morgan Stanley Investment Management Inc. | Passiv (13G) | 5,40 % | 5.475.255 | +0,90 pp | |
| 10.02.2022 | Morgan Stanley | Passiv (13G) | 5,60 % | 5.714.358 | Neu | |
| 03.02.2022 | . BlackRock, Inc. | Passiv (13G/A) | 5,00 % | 5.110.230 | -0,30 pp | |
| 18.01.2022 | Viking Global Performance LLC | Passiv (13G) | 3,40 % | 3.431.009 | Neu | |
| 18.01.2022 | Viking Long Fund Master Ltd. (+1) | Passiv (13G) | 1,30 % | 1.279.765 | Neu | |
| 18.01.2022 | Viking Global Opportunities Liquid Portfolio Sub-Master LP (+3) | Passiv (13G) | 0,40 % | 411.721 | Neu | |
| 18.01.2022 | Viking Global Investors LP (+3) | Passiv (13G) | 5,00 % | 5.122.495 | Neu |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 21.11.2025 | Sheldon Whitehouse | – | Senate | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 301.665.000 $ | -112.075.000 $ | -0,85 $ | 1.915.291.000 $ | -181.073.000 $ |
| 2025-12-31 | 10-K | 982.021.000 $ | -416.277.000 $ | -3,32 $ | 2.013.659.000 $ | -99.307.000 $ |
| 2025-09-30 | 10-Q | 265.196.000 $ | -92.725.000 $ | -0,74 $ | 1.276.786.000 $ | -354.473.000 $ |
| 2025-06-30 | 10-Q | 232.088.000 $ | -99.899.000 $ | -0,80 $ | 1.331.999.000 $ | -305.475.000 $ |
| 2025-03-31 | 10-Q | 203.471.000 $ | -95.159.000 $ | -0,77 $ | 1.344.226.000 $ | -250.789.000 $ |
| 2024-12-31 | 10-K | 739.016.000 $ | -436.373.000 $ | -3,56 $ | 1.485.609.000 $ | -139.647.000 $ |
| 2024-09-30 | 10-Q | 191.476.000 $ | -107.754.000 $ | -0,88 $ | 1.538.727.000 $ | -60.096.000 $ |
| 2024-06-30 | 10-Q | 177.235.000 $ | -102.628.000 $ | -0,84 $ | 1.609.340.000 $ | -1.613.000 $ |
| 2024-03-31 | 10-Q | 168.491.000 $ | -114.985.000 $ | -0,94 $ | 1.704.598.000 $ | 68.285.000 $ |
| 2023-12-31 | 10-K | 563.948.000 $ | -479.449.000 $ | -4,28 $ | 1.786.421.000 $ | 158.684.000 $ |
| 2023-09-30 | 10-Q | 143.030.000 $ | -86.102.000 $ | -0,73 $ | 1.797.231.000 $ | 228.299.000 $ |
| 2023-06-30 | 10-Q | 137.150.000 $ | -72.771.000 $ | -0,67 $ | 1.840.017.000 $ | 292.726.000 $ |
| 2023-03-31 | 10-Q | 128.714.000 $ | -133.533.000 $ | -1,30 $ | 1.511.631.000 $ | -44.551.000 $ |
| 2022-12-31 | 10-K | 449.538.000 $ | -654.588.000 $ | -6,41 $ | 1.609.985.000 $ | 60.180.000 $ |
| 2022-09-30 | 10-Q | 117.404.000 $ | -161.994.000 $ | -1,58 $ | 1.701.779.000 $ | 166.745.000 $ |
| 2022-06-30 | 10-Q | 109.144.000 $ | -229.432.000 $ | -2,25 $ | 1.853.737.000 $ | 319.087.000 $ |
| 2022-03-31 | 10-Q | 96.099.000 $ | -123.228.000 $ | -1,21 $ | 2.129.598.000 $ | 533.040.000 $ |
| 2021-12-31 | 10-K | 373.653.000 $ | -384.770.000 $ | -4,00 $ | 2.204.499.000 $ | 645.005.000 $ |
| 2021-09-30 | 10-Q | 94.779.000 $ | – | -1,06 $ | 2.225.534.000 $ | 709.420.000 $ |
| 2021-06-30 | 10-Q | 92.101.000 $ | – | -0,96 $ | 2.291.885.000 $ | 788.065.000 $ |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Reportable Segment | 982,0 Mio. | 739,0 Mio. | 563,9 Mio. | 449,5 Mio. | 100,0 % | +32,9% |
Quartalsverlauf
| Segment | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|
| Reportable Segment | 265,2 Mio. | 232,1 Mio. | 203,5 Mio. | 100,0 % | – |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 923,3 Mio. | 697,2 Mio. | 526,5 Mio. | 420,6 Mio. | 352,6 Mio. | 94,0 % | +32,4% | |
| Non Us | 58,7 Mio. | 41,9 Mio. | 37,4 Mio. | 28,9 Mio. | 21,1 Mio. | 6,0 % | +40,3% |
Quartalsverlauf
| Region | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|---|
| US | 249,4 Mio. | 216,7 Mio. | 193,6 Mio. | 180,1 Mio. | 168,1 Mio. | 157,3 Mio. | 94,1 % | +38,5% | |
| Non Us | 15,8 Mio. | 15,4 Mio. | 9,9 Mio. | 11,4 Mio. | 9,1 Mio. | 11,1 Mio. | 5,9 % | +38,6% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | 301,7 Mio. USD | -0,85 |
| Q3 2025 | 30.09.2025 | 29.10.2025 | 265,2 Mio. USD | -0,74 |
| Q2 2025 | 30.06.2025 | 30.07.2025 | 232,1 Mio. USD | -0,80 |
| Q1 2025 | 31.03.2025 | 30.04.2025 | 203,5 Mio. USD | -0,77 |
| Q3 2024 | 30.09.2024 | 06.11.2024 | 191,5 Mio. USD | -0,88 |
| Q2 2024 | 30.06.2024 | 07.08.2024 | 177,2 Mio. USD | -0,84 |
| Q1 2024 | 31.03.2024 | 09.05.2024 | 168,5 Mio. USD | -0,94 |
| Q3 2023 | 30.09.2023 | 06.11.2023 | 143,0 Mio. USD | -0,73 |
| Q2 2023 | 30.06.2023 | 03.08.2023 | 137,2 Mio. USD | -0,67 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | 31.03.2026 | 37 Tage | SEC » |
| 19.02.2026 | 10-K | 31.12.2025 | 50 Tage | SEC » |
| 29.10.2025 | 10-Q | 30.09.2025 | 29 Tage | SEC » |
| 30.07.2025 | 10-Q | 30.06.2025 | 30 Tage | SEC » |
| 30.04.2025 | 10-Q | 31.03.2025 | 30 Tage | SEC » |
| 20.02.2025 | 10-K | 31.12.2024 | 51 Tage | SEC » |
| 06.11.2024 | 10-Q | 30.09.2024 | 37 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 22.02.2024 | 10-K | 31.12.2023 | 53 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 09.05.2023 | 10-Q | 31.03.2023 | 39 Tage | SEC » |
| 23.02.2023 | 10-K | 31.12.2022 | 54 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 24.02.2022 | 10-K | 31.12.2021 | 55 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 25.02.2021 | 10-K | 31.12.2020 | 56 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 06.11.2025 | Kapitalerhöhung | $300,0 Mio · $90,00/Aktie | SEC » |
| 04.11.2025 | Kapitalerhöhung | $250,0 Mio | SEC » |
| 23.08.2024 | Kapitalerhöhung | $400,0 Mio | SEC » |
| 21.12.2023 | Kapitalerhöhung | $90,7 Mio · $26,77/Aktie | SEC » |
| 24.05.2023 | Kapitalerhöhung | $350,0 Mio · $28,00/Aktie | SEC » |
| 22.05.2023 | Kapitalerhöhung | $250,0 Mio | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 28.04.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 28.04.2026 | HV-Einladung | 17.06.2026 Jahres-HV | 20.04.2026 | DEF 14A | SEC » |
| 29.04.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2025 | HV-Einladung | 18.06.2025 Jahres-HV | 21.04.2025 | DEF 14A | SEC » |
| 25.04.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 25.04.2024 | HV-Einladung | 12.06.2024 Jahres-HV | 15.04.2024 | DEF 14A | SEC » |
| 27.04.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 27.04.2023 | HV-Einladung | 14.06.2023 Jahres-HV | 17.04.2023 | DEF 14A | SEC » |
| 08.06.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 28.04.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 28.04.2022 | HV-Einladung | 15.06.2022 Jahres-HV | 18.04.2022 | DEF 14A | SEC » |
| 29.04.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2021 | HV-Einladung | 16.06.2021 Jahres-HV | 19.04.2021 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 15.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | (a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
| 06.10.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 of the Original Report to include updated disclosure regarding the departure date of the Company’s Chief… |
| 24.02.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 12.01.2026 | Quartalszahlen | 0,00 | 70 | Guardant Health kündigte am 11. Januar 2026 vorläufige unverevisierte Finanzergebnisse für Q4 und Gesamtjahr 2025 an. Die Präsentation zur J… 🔒 | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-22 | 182 | 131,78 | 23.984 |
| 2026-06-18 | 119.025 | 129,11 | 15.367.318 |
| 2026-06-15 | 18 | 131,62 | 2.369 |
| 2026-06-11 | 19 | 130,70 | 2.483 |
| 2026-06-10 | 107 | 130,12 | 13.923 |
| 2026-05-29 | 1 | 133,22 | 133 |
| 2026-05-26 | 778 | 118,95 | 92.543 |
| 2026-05-20 | 4 | 98,19 | 393 |
| 2026-05-14 | 5 | 98,47 | 492 |
| 2026-05-13 | 65.529 | 99,94 | 6.548.968 |
| 2026-05-12 | 5 | 96,71 | 484 |
| 2026-04-27 | 672 | 88,91 | 59.748 |
| 2026-04-24 | 25.922 | 87,87 | 2.277.766 |
| 2026-04-23 | 55.094 | 89,56 | 4.934.219 |
| 2026-04-22 | 12.999 | 90,36 | 1.174.590 |
| 2026-04-21 | 3.028 | 91,07 | 275.760 |
| 2026-04-20 | 482 | 90,36 | 43.554 |
| 2026-04-17 | 1.252 | 85,70 | 107.296 |
| 2026-04-15 | 28 | 86,40 | 2.419 |
| 2026-04-10 | 9.976 | 87,17 | 869.608 |
| 2026-04-09 | 1.464 | 92,84 | 135.918 |
| 2026-04-06 | 10.608 | 93,83 | 995.349 |
| 2026-03-25 | 11 | 83,59 | 919 |
| 2026-03-16 | 6.737 | 85,49 | 575.946 |
| 2026-03-11 | 92 | 90,49 | 8.325 |
| 2026-03-06 | 440 | 92,58 | 40.735 |
| 2026-03-03 | 648 | 92,23 | 59.765 |
| 2026-02-27 | 4.569 | 97,97 | 447.625 |
| 2026-02-24 | 201 | 94,42 | 18.978 |
| 2026-02-18 | 790 | 107,11 | 84.617 |
| 2026-02-13 | 30 | 102,76 | 3.083 |
| 2026-02-12 | 100 | 107,58 | 10.758 |
| 2026-02-10 | 5 | 105,34 | 527 |
| 2026-02-03 | 120 | 114,90 | 13.788 |
| 2026-02-02 | 157 | 114,04 | 17.904 |
| 2026-01-30 | 20 | 110,48 | 2.210 |